Mitochondrial Activity as a Biomarker of Gamete and Embryo Health
Author:
Van Blerkom Jonathan
Publisher
Springer New York
Reference119 articles.
1. Van Blerkom J, Henry G. Oocyte dysmorphism and aneuploidy in meiotically mature human oocytes after controlled ovarian stimulation. Hum Reprod. 1992;7:379–90.
2. Meriano J, Alexis J, Visram-Zaver J, et al. Tracking of oocyte dysmorphisms for ICSI patients may prove relevant to outcome in subsequent patient cycles. Hum Reprod. 2001;16:2118–23.
3. de Cássia S Figueira S, de Almeida Ferreira Braga DP, Semiao-Francisco L, Madaschi C, Iaconeli A, Borges E. Metaphase II human oocyte morphology: contributing factors and effects on fertilization potential and embryo developmental ability in ICSI cycles. Fertil Steril. 2010;94:1115–7.
4. Balaban B et al. Alpha scientists in reproductive medicine and ESHRE special interest group of embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–83.
5. Lemmen J, Agerholm I, Ziebe S. Kinetic markers of human embryo quality using time-lapse recordings of IVF/ICSI-fertilized oocytes. Reprod Biomed Online. 2008;17:385–91.